Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() United States Non Invasive Prenatal Testing(NIPT) Market Research Report 2023 - 2031The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031. The market is expected to register a CAGR of more than 13% in the forecast period.
By: DPI Research "United States Non Invasive Prenatal Testing(NIPT) The non-invasive prenatal testing (NIPT) market in the United States is expected to reach USD 2,653 million by 2031. The market is expected to register a CAGR of more than 13% in the forecast period. The growth of the market depends on several factors, including the increase in the incidence of chromosomal aneuploidies in fetuses, the progress of advanced non-invasive prenatal testing products, the increasing acceptance of non-invasive prenatal testing, the growing focus on reimbursement for non-invasive prenatal testing, the rising preference for non-invasive techniques over invasive methods, and the ACOG guidelines recommending NIPT for all pregnancies regardless of risk. The report on the non-invasive prenatal testing (NIPT) market in the United States is a comprehensive study and presentation of drivers, restraints, opportunities, demand, market size, insights, forecasts, and trends in the non-invasive prenatal testing (NIPT) market in the United States during 2019 – 2031. Furthermore, the report includes historic market data from 2019 to 2022 and forecast until 2031. Key Players in the United States Non–Invasive Prenatal Testing Market are Listed Below: Illumina, Inc. Natera, Inc. Quest Diagnostics Myriad Genetics, Inc. Centogene GenPath PerkinElmer Yourgene Health Invitae Corporation Agilent Technologies Ariosa Diagnostics (Roche) Laboratory Corporation of America Holdings(Labcorp) Browse In-depth Market Research Report (150 Pages, Charts, Tables, Figures) on NIPT Test Market - https://dpiresearch.com/ End
|
|